 | • レポートコード：MRC2-11QY12063 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は糖化ヘモグロビン検査のグローバル市場について調査・分析したレポートです。種類別（ラボ検査、ポイントオブケア検査）市場規模、用途別（病院、診断センター、学術・研究機関、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別糖化ヘモグロビン検査の競争状況、市場シェア ・世界の糖化ヘモグロビン検査市場：種類別市場規模 2015年-2020年（ラボ検査、ポイントオブケア検査） ・世界の糖化ヘモグロビン検査市場：種類別市場規模予測 2021年-2026年（ラボ検査、ポイントオブケア検査） ・世界の糖化ヘモグロビン検査市場：用途別市場規模 2015年-2020年（病院、診断センター、学術・研究機関、その他） ・世界の糖化ヘモグロビン検査市場：用途別市場規模予測 2021年-2026年（病院、診断センター、学術・研究機関、その他） ・北米の糖化ヘモグロビン検査市場分析：米国、カナダ ・ヨーロッパの糖化ヘモグロビン検査市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの糖化ヘモグロビン検査市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の糖化ヘモグロビン検査市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの糖化ヘモグロビン検査市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bio-Rad Laboratories、Bayer、Arkray、Chek Diagnostics、Diazyme Laboratories、X Lite-On Technology、TaiDoc Technology、Trinity Biotech、Siemens Healthcare、Ceragem Medisys、Tosoh Bioscience、DiaSys Diagnostic Systems、Erba Mannheim、Daiichi Biotech、Human Diagnostics、EKF Diagnostics、Mindray Medical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Growing adoption of a sedentary lifestyle and genetic manipulation causes type 1 or type 2 diseases. Globally, more than 400 million adults suffer from diabetes, out of which half of the incidences of diabetes remain undiagnosed.
In recent times there is increased use of glycated haemoglobin testing due to increasing incidence of diabetics among the population. Growing awareness of haemoglobin A1c testing among patients and medical practitioners and aging population are some of the key factors driving the growth for global glycated haemoglobin testing market.
Market Analysis and Insights: Global Glycated Haemoglobin Testing Market
The global Glycated Haemoglobin Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Glycated Haemoglobin Testing Scope and Market Size
Glycated Haemoglobin Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Glycated Haemoglobin Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Bio-Rad Laboratories
Bayer
Arkray
Chek Diagnostics
Diazyme Laboratories
X Lite-On Technology
TaiDoc Technology
Trinity Biotech
Siemens Healthcare
Ceragem Medisys
Tosoh Bioscience
DiaSys Diagnostic Systems
Erba Mannheim
Daiichi Biotech
Human Diagnostics
EKF Diagnostics
Mindray Medical
Market segment by Type, the product can be split into
Lab Based Test
Point-of-care Test
Market segment by Application, split into
Hospitals
Diagnostic Centers
Academic and Research Institutes
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Glycated Haemoglobin Testing Revenue
1.4 Market by Type
1.4.1 Global Glycated Haemoglobin Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Lab Based Test
1.4.3 Point-of-care Test
1.5 Market by Application
1.5.1 Global Glycated Haemoglobin Testing Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Diagnostic Centers
1.5.4 Academic and Research Institutes
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Glycated Haemoglobin Testing Market Perspective (2015-2026)
2.2 Global Glycated Haemoglobin Testing Growth Trends by Regions
2.2.1 Glycated Haemoglobin Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Glycated Haemoglobin Testing Historic Market Share by Regions (2015-2020)
2.2.3 Glycated Haemoglobin Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Glycated Haemoglobin Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Glycated Haemoglobin Testing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Glycated Haemoglobin Testing Players by Market Size
3.1.1 Global Top Glycated Haemoglobin Testing Players by Revenue (2015-2020)
3.1.2 Global Glycated Haemoglobin Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Glycated Haemoglobin Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Glycated Haemoglobin Testing Market Concentration Ratio
3.2.1 Global Glycated Haemoglobin Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Glycated Haemoglobin Testing Revenue in 2019
3.3 Glycated Haemoglobin Testing Key Players Head office and Area Served
3.4 Key Players Glycated Haemoglobin Testing Product Solution and Service
3.5 Date of Enter into Glycated Haemoglobin Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Glycated Haemoglobin Testing Historic Market Size by Type (2015-2020)
4.2 Global Glycated Haemoglobin Testing Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Glycated Haemoglobin Testing Market Size by Application (2015-2020)
5.2 Global Glycated Haemoglobin Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Glycated Haemoglobin Testing Market Size (2015-2020)
6.2 Glycated Haemoglobin Testing Key Players in North America (2019-2020)
6.3 North America Glycated Haemoglobin Testing Market Size by Type (2015-2020)
6.4 North America Glycated Haemoglobin Testing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Glycated Haemoglobin Testing Market Size (2015-2020)
7.2 Glycated Haemoglobin Testing Key Players in Europe (2019-2020)
7.3 Europe Glycated Haemoglobin Testing Market Size by Type (2015-2020)
7.4 Europe Glycated Haemoglobin Testing Market Size by Application (2015-2020)
8 China
8.1 China Glycated Haemoglobin Testing Market Size (2015-2020)
8.2 Glycated Haemoglobin Testing Key Players in China (2019-2020)
8.3 China Glycated Haemoglobin Testing Market Size by Type (2015-2020)
8.4 China Glycated Haemoglobin Testing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Glycated Haemoglobin Testing Market Size (2015-2020)
9.2 Glycated Haemoglobin Testing Key Players in Japan (2019-2020)
9.3 Japan Glycated Haemoglobin Testing Market Size by Type (2015-2020)
9.4 Japan Glycated Haemoglobin Testing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Glycated Haemoglobin Testing Market Size (2015-2020)
10.2 Glycated Haemoglobin Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Glycated Haemoglobin Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Glycated Haemoglobin Testing Market Size by Application (2015-2020)
11 India
11.1 India Glycated Haemoglobin Testing Market Size (2015-2020)
11.2 Glycated Haemoglobin Testing Key Players in India (2019-2020)
11.3 India Glycated Haemoglobin Testing Market Size by Type (2015-2020)
11.4 India Glycated Haemoglobin Testing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Glycated Haemoglobin Testing Market Size (2015-2020)
12.2 Glycated Haemoglobin Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Glycated Haemoglobin Testing Market Size by Type (2015-2020)
12.4 Central & South America Glycated Haemoglobin Testing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bio-Rad Laboratories
13.1.1 Bio-Rad Laboratories Company Details
13.1.2 Bio-Rad Laboratories Business Overview
13.1.3 Bio-Rad Laboratories Glycated Haemoglobin Testing Introduction
13.1.4 Bio-Rad Laboratories Revenue in Glycated Haemoglobin Testing Business (2015-2020))
13.1.5 Bio-Rad Laboratories Recent Development
13.2 Bayer
13.2.1 Bayer Company Details
13.2.2 Bayer Business Overview
13.2.3 Bayer Glycated Haemoglobin Testing Introduction
13.2.4 Bayer Revenue in Glycated Haemoglobin Testing Business (2015-2020)
13.2.5 Bayer Recent Development
13.3 Arkray
13.3.1 Arkray Company Details
13.3.2 Arkray Business Overview
13.3.3 Arkray Glycated Haemoglobin Testing Introduction
13.3.4 Arkray Revenue in Glycated Haemoglobin Testing Business (2015-2020)
13.3.5 Arkray Recent Development
13.4 Chek Diagnostics
13.4.1 Chek Diagnostics Company Details
13.4.2 Chek Diagnostics Business Overview
13.4.3 Chek Diagnostics Glycated Haemoglobin Testing Introduction
13.4.4 Chek Diagnostics Revenue in Glycated Haemoglobin Testing Business (2015-2020)
13.4.5 Chek Diagnostics Recent Development
13.5 Diazyme Laboratories
13.5.1 Diazyme Laboratories Company Details
13.5.2 Diazyme Laboratories Business Overview
13.5.3 Diazyme Laboratories Glycated Haemoglobin Testing Introduction
13.5.4 Diazyme Laboratories Revenue in Glycated Haemoglobin Testing Business (2015-2020)
13.5.5 Diazyme Laboratories Recent Development
13.6 X Lite-On Technology
13.6.1 X Lite-On Technology Company Details
13.6.2 X Lite-On Technology Business Overview
13.6.3 X Lite-On Technology Glycated Haemoglobin Testing Introduction
13.6.4 X Lite-On Technology Revenue in Glycated Haemoglobin Testing Business (2015-2020)
13.6.5 X Lite-On Technology Recent Development
13.7 TaiDoc Technology
13.7.1 TaiDoc Technology Company Details
13.7.2 TaiDoc Technology Business Overview
13.7.3 TaiDoc Technology Glycated Haemoglobin Testing Introduction
13.7.4 TaiDoc Technology Revenue in Glycated Haemoglobin Testing Business (2015-2020)
13.7.5 TaiDoc Technology Recent Development
13.8 Trinity Biotech
13.8.1 Trinity Biotech Company Details
13.8.2 Trinity Biotech Business Overview
13.8.3 Trinity Biotech Glycated Haemoglobin Testing Introduction
13.8.4 Trinity Biotech Revenue in Glycated Haemoglobin Testing Business (2015-2020)
13.8.5 Trinity Biotech Recent Development
13.9 Siemens Healthcare
13.9.1 Siemens Healthcare Company Details
13.9.2 Siemens Healthcare Business Overview
13.9.3 Siemens Healthcare Glycated Haemoglobin Testing Introduction
13.9.4 Siemens Healthcare Revenue in Glycated Haemoglobin Testing Business (2015-2020)
13.9.5 Siemens Healthcare Recent Development
13.10 Ceragem Medisys
13.10.1 Ceragem Medisys Company Details
13.10.2 Ceragem Medisys Business Overview
13.10.3 Ceragem Medisys Glycated Haemoglobin Testing Introduction
13.10.4 Ceragem Medisys Revenue in Glycated Haemoglobin Testing Business (2015-2020)
13.10.5 Ceragem Medisys Recent Development
13.11 Tosoh Bioscience
10.11.1 Tosoh Bioscience Company Details
10.11.2 Tosoh Bioscience Business Overview
10.11.3 Tosoh Bioscience Glycated Haemoglobin Testing Introduction
10.11.4 Tosoh Bioscience Revenue in Glycated Haemoglobin Testing Business (2015-2020)
10.11.5 Tosoh Bioscience Recent Development
13.12 DiaSys Diagnostic Systems
10.12.1 DiaSys Diagnostic Systems Company Details
10.12.2 DiaSys Diagnostic Systems Business Overview
10.12.3 DiaSys Diagnostic Systems Glycated Haemoglobin Testing Introduction
10.12.4 DiaSys Diagnostic Systems Revenue in Glycated Haemoglobin Testing Business (2015-2020)
10.12.5 DiaSys Diagnostic Systems Recent Development
13.13 Erba Mannheim
10.13.1 Erba Mannheim Company Details
10.13.2 Erba Mannheim Business Overview
10.13.3 Erba Mannheim Glycated Haemoglobin Testing Introduction
10.13.4 Erba Mannheim Revenue in Glycated Haemoglobin Testing Business (2015-2020)
10.13.5 Erba Mannheim Recent Development
13.14 Daiichi Biotech
10.14.1 Daiichi Biotech Company Details
10.14.2 Daiichi Biotech Business Overview
10.14.3 Daiichi Biotech Glycated Haemoglobin Testing Introduction
10.14.4 Daiichi Biotech Revenue in Glycated Haemoglobin Testing Business (2015-2020)
10.14.5 Daiichi Biotech Recent Development
13.15 Human Diagnostics
10.15.1 Human Diagnostics Company Details
10.15.2 Human Diagnostics Business Overview
10.15.3 Human Diagnostics Glycated Haemoglobin Testing Introduction
10.15.4 Human Diagnostics Revenue in Glycated Haemoglobin Testing Business (2015-2020)
10.15.5 Human Diagnostics Recent Development
13.16 EKF Diagnostics
10.16.1 EKF Diagnostics Company Details
10.16.2 EKF Diagnostics Business Overview
10.16.3 EKF Diagnostics Glycated Haemoglobin Testing Introduction
10.16.4 EKF Diagnostics Revenue in Glycated Haemoglobin Testing Business (2015-2020)
10.16.5 EKF Diagnostics Recent Development
13.17 Mindray Medical
10.17.1 Mindray Medical Company Details
10.17.2 Mindray Medical Business Overview
10.17.3 Mindray Medical Glycated Haemoglobin Testing Introduction
10.17.4 Mindray Medical Revenue in Glycated Haemoglobin Testing Business (2015-2020)
10.17.5 Mindray Medical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Glycated Haemoglobin Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Glycated Haemoglobin Testing Revenue
Table 3. Ranking of Global Top Glycated Haemoglobin Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Glycated Haemoglobin Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Lab Based Test
Table 6. Key Players of Point-of-care Test
Table 7. Global Glycated Haemoglobin Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Glycated Haemoglobin Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Glycated Haemoglobin Testing Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Glycated Haemoglobin Testing Market Share by Regions (2015-2020)
Table 11. Global Glycated Haemoglobin Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Glycated Haemoglobin Testing Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Glycated Haemoglobin Testing Market Growth Strategy
Table 17. Main Points Interviewed from Key Glycated Haemoglobin Testing Players
Table 18. Global Glycated Haemoglobin Testing Revenue by Players (2015-2020) (Million US$)
Table 19. Global Glycated Haemoglobin Testing Market Share by Players (2015-2020)
Table 20. Global Top Glycated Haemoglobin Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glycated Haemoglobin Testing as of 2019)
Table 21. Global Glycated Haemoglobin Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Glycated Haemoglobin Testing Product Solution and Service
Table 24. Date of Enter into Glycated Haemoglobin Testing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Glycated Haemoglobin Testing Market Size by Type (2015-2020) (Million US$)
Table 27. Global Glycated Haemoglobin Testing Market Size Share by Type (2015-2020)
Table 28. Global Glycated Haemoglobin Testing Revenue Market Share by Type (2021-2026)
Table 29. Global Glycated Haemoglobin Testing Market Size Share by Application (2015-2020)
Table 30. Global Glycated Haemoglobin Testing Market Size by Application (2015-2020) (Million US$)
Table 31. Global Glycated Haemoglobin Testing Market Size Share by Application (2021-2026)
Table 32. North America Key Players Glycated Haemoglobin Testing Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Glycated Haemoglobin Testing Market Share (2019-2020)
Table 34. North America Glycated Haemoglobin Testing Market Size by Type (2015-2020) (Million US$)
Table 35. North America Glycated Haemoglobin Testing Market Share by Type (2015-2020)
Table 36. North America Glycated Haemoglobin Testing Market Size by Application (2015-2020) (Million US$)
Table 37. North America Glycated Haemoglobin Testing Market Share by Application (2015-2020)
Table 38. Europe Key Players Glycated Haemoglobin Testing Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Glycated Haemoglobin Testing Market Share (2019-2020)
Table 40. Europe Glycated Haemoglobin Testing Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Glycated Haemoglobin Testing Market Share by Type (2015-2020)
Table 42. Europe Glycated Haemoglobin Testing Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Glycated Haemoglobin Testing Market Share by Application (2015-2020)
Table 44. China Key Players Glycated Haemoglobin Testing Revenue (2019-2020) (Million US$)
Table 45. China Key Players Glycated Haemoglobin Testing Market Share (2019-2020)
Table 46. China Glycated Haemoglobin Testing Market Size by Type (2015-2020) (Million US$)
Table 47. China Glycated Haemoglobin Testing Market Share by Type (2015-2020)
Table 48. China Glycated Haemoglobin Testing Market Size by Application (2015-2020) (Million US$)
Table 49. China Glycated Haemoglobin Testing Market Share by Application (2015-2020)
Table 50. Japan Key Players Glycated Haemoglobin Testing Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Glycated Haemoglobin Testing Market Share (2019-2020)
Table 52. Japan Glycated Haemoglobin Testing Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Glycated Haemoglobin Testing Market Share by Type (2015-2020)
Table 54. Japan Glycated Haemoglobin Testing Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Glycated Haemoglobin Testing Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Glycated Haemoglobin Testing Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Glycated Haemoglobin Testing Market Share (2019-2020)
Table 58. Southeast Asia Glycated Haemoglobin Testing Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Glycated Haemoglobin Testing Market Share by Type (2015-2020)
Table 60. Southeast Asia Glycated Haemoglobin Testing Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Glycated Haemoglobin Testing Market Share by Application (2015-2020)
Table 62. India Key Players Glycated Haemoglobin Testing Revenue (2019-2020) (Million US$)
Table 63. India Key Players Glycated Haemoglobin Testing Market Share (2019-2020)
Table 64. India Glycated Haemoglobin Testing Market Size by Type (2015-2020) (Million US$)
Table 65. India Glycated Haemoglobin Testing Market Share by Type (2015-2020)
Table 66. India Glycated Haemoglobin Testing Market Size by Application (2015-2020) (Million US$)
Table 67. India Glycated Haemoglobin Testing Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Glycated Haemoglobin Testing Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Glycated Haemoglobin Testing Market Share (2019-2020)
Table 70. Central & South America Glycated Haemoglobin Testing Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Glycated Haemoglobin Testing Market Share by Type (2015-2020)
Table 72. Central & South America Glycated Haemoglobin Testing Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Glycated Haemoglobin Testing Market Share by Application (2015-2020)
Table 74. Bio-Rad Laboratories Company Details
Table 75. Bio-Rad Laboratories Business Overview
Table 76. Bio-Rad Laboratories Product
Table 77. Bio-Rad Laboratories Revenue in Glycated Haemoglobin Testing Business (2015-2020) (Million US$)
Table 78. Bio-Rad Laboratories Recent Development
Table 79. Bayer Company Details
Table 80. Bayer Business Overview
Table 81. Bayer Product
Table 82. Bayer Revenue in Glycated Haemoglobin Testing Business (2015-2020) (Million US$)
Table 83. Bayer Recent Development
Table 84. Arkray Company Details
Table 85. Arkray Business Overview
Table 86. Arkray Product
Table 87. Arkray Revenue in Glycated Haemoglobin Testing Business (2015-2020) (Million US$)
Table 88. Arkray Recent Development
Table 89. Chek Diagnostics Company Details
Table 90. Chek Diagnostics Business Overview
Table 91. Chek Diagnostics Product
Table 92. Chek Diagnostics Revenue in Glycated Haemoglobin Testing Business (2015-2020) (Million US$)
Table 93. Chek Diagnostics Recent Development
Table 94. Diazyme Laboratories Company Details
Table 95. Diazyme Laboratories Business Overview
Table 96. Diazyme Laboratories Product
Table 97. Diazyme Laboratories Revenue in Glycated Haemoglobin Testing Business (2015-2020) (Million US$)
Table 98. Diazyme Laboratories Recent Development
Table 99. X Lite-On Technology Company Details
Table 100. X Lite-On Technology Business Overview
Table 101. X Lite-On Technology Product
Table 102. X Lite-On Technology Revenue in Glycated Haemoglobin Testing Business (2015-2020) (Million US$)
Table 103. X Lite-On Technology Recent Development
Table 104. TaiDoc Technology Company Details
Table 105. TaiDoc Technology Business Overview
Table 106. TaiDoc Technology Product
Table 107. TaiDoc Technology Revenue in Glycated Haemoglobin Testing Business (2015-2020) (Million US$)
Table 108. TaiDoc Technology Recent Development
Table 109. Trinity Biotech Business Overview
Table 110. Trinity Biotech Product
Table 111. Trinity Biotech Company Details
Table 112. Trinity Biotech Revenue in Glycated Haemoglobin Testing Business (2015-2020) (Million US$)
Table 113. Trinity Biotech Recent Development
Table 114. Siemens Healthcare Company Details
Table 115. Siemens Healthcare Business Overview
Table 116. Siemens Healthcare Product
Table 117. Siemens Healthcare Revenue in Glycated Haemoglobin Testing Business (2015-2020) (Million US$)
Table 118. Siemens Healthcare Recent Development
Table 119. Ceragem Medisys Company Details
Table 120. Ceragem Medisys Business Overview
Table 121. Ceragem Medisys Product
Table 122. Ceragem Medisys Revenue in Glycated Haemoglobin Testing Business (2015-2020) (Million US$)
Table 123. Ceragem Medisys Recent Development
Table 124. Tosoh Bioscience Company Details
Table 125. Tosoh Bioscience Business Overview
Table 126. Tosoh Bioscience Product
Table 127. Tosoh Bioscience Revenue in Glycated Haemoglobin Testing Business (2015-2020) (Million US$)
Table 128. Tosoh Bioscience Recent Development
Table 129. DiaSys Diagnostic Systems Company Details
Table 130. DiaSys Diagnostic Systems Business Overview
Table 131. DiaSys Diagnostic Systems Product
Table 132. DiaSys Diagnostic Systems Revenue in Glycated Haemoglobin Testing Business (2015-2020) (Million US$)
Table 133. DiaSys Diagnostic Systems Recent Development
Table 134. Erba Mannheim Company Details
Table 135. Erba Mannheim Business Overview
Table 136. Erba Mannheim Product
Table 137. Erba Mannheim Revenue in Glycated Haemoglobin Testing Business (2015-2020) (Million US$)
Table 138. Erba Mannheim Recent Development
Table 139. Daiichi Biotech Company Details
Table 140. Daiichi Biotech Business Overview
Table 141. Daiichi Biotech Product
Table 142. Daiichi Biotech Revenue in Glycated Haemoglobin Testing Business (2015-2020) (Million US$)
Table 143. Daiichi Biotech Recent Development
Table 144. Human Diagnostics Company Details
Table 145. Human Diagnostics Business Overview
Table 146. Human Diagnostics Product
Table 147. Human Diagnostics Revenue in Glycated Haemoglobin Testing Business (2015-2020) (Million US$)
Table 148. Human Diagnostics Recent Development
Table 149. EKF Diagnostics Company Details
Table 150. EKF Diagnostics Business Overview
Table 151. EKF Diagnostics Product
Table 152. EKF Diagnostics Revenue in Glycated Haemoglobin Testing Business (2015-2020) (Million US$)
Table 153. EKF Diagnostics Recent Development
Table 154. Mindray Medical Company Details
Table 155. Mindray Medical Business Overview
Table 156. Mindray Medical Product
Table 157. Mindray Medical Revenue in Glycated Haemoglobin Testing Business (2015-2020) (Million US$)
Table 158. Mindray Medical Recent Development
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Glycated Haemoglobin Testing Market Share by Type: 2020 VS 2026
Figure 2. Lab Based Test Features
Figure 3. Point-of-care Test Features
Figure 4. Global Glycated Haemoglobin Testing Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Diagnostic Centers Case Studies
Figure 7. Academic and Research Institutes Case Studies
Figure 8. Others Case Studies
Figure 9. Glycated Haemoglobin Testing Report Years Considered
Figure 10. Global Glycated Haemoglobin Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Glycated Haemoglobin Testing Market Share by Regions: 2020 VS 2026
Figure 12. Global Glycated Haemoglobin Testing Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Glycated Haemoglobin Testing Market Share by Players in 2019
Figure 15. Global Top Glycated Haemoglobin Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glycated Haemoglobin Testing as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Glycated Haemoglobin Testing Revenue in 2019
Figure 17. North America Glycated Haemoglobin Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Glycated Haemoglobin Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Glycated Haemoglobin Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Glycated Haemoglobin Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Glycated Haemoglobin Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Glycated Haemoglobin Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Glycated Haemoglobin Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
免疫タンパク質診断検査の世界市場（～2026年） Immunoprotein is an immunologically active protein, which provides immunity against pathogenic organisms or substances. These proteins form the integrated body system of tissues, organs, cells, or cell products that neutralize antigens. They enable the diagnosis of various diseases, such as cardiova…- ポイントオブケア遺伝子検査の世界市場（～2026年） Market Analysis and Insights: Global Point-of-Care Genetic Testing Market The global Point-of-Care Genetic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Point-of-Care Genetic Testing Scope and Market Size Poi…
- 髄膜炎診断検査の世界市場（～2026年） Inflammation to the meninges is known as meningitis. Most common cause of meningitis is bacteria or virus. Other causes include certain illness, medications or suffering from some other disease such as tuberculosis, or HIV (Human Immunodeficiency Virus). The testing for meningitis can be done using …
- ポイントオブケア凝固検査の世界市場（～2026年） POCT, also called near-patient testing, is performed outside a clinical laboratory. The increasing penetration of POCT devices in developed countries is one of the significant factors driving the growth of this market. Market Analysis and Insights: Global Point-of-Care Coagulation Testing Market The…
- 診療所用診断検査の世界市場（～2026年） Physician office diagnostic testing is similar to the point-of-care diagnostic testing which are carried out in physician’s office, hospital, home and others. The physician office diagnostic testing market is expected to grow at a rapid growth rate over the forecast period owing to the increasing se…